Analyzing 8-MOP Pharmacokinetics
Reference39 articles.
1. Andersen, K. E., Menne, T., Gammeltoft, M., Hjorth, N., Larsen, E., and Solgaard, P., 1980 Pharmacokinetic and clinical comparison of two 8-methoxypsoralen brands, Arch
Dermatol
Res 268: 23–29. 2. Andrew, E., Nilsen, A., Thune, P., and Wiik, I., 1981, Photechemotherapy in psoriasis-clinical response and 8-MOP plasma concentrations at two dose levels, Clin
Exp
Dermatol 6: 591–600. 3. Bonnot, D., Beani, J. C., Beriel, H., Boitard, M., Amblard, P., and Reymond, J. L., 1985, Influence of the diet on the plasma kinetics of 8-methoxypsoralen, Dermatologica 171: 442 –445. 4. Brickl, R., Schmid, J., and Koss, F. W., 1984, Clinical pharmacology of oral psoralen drugs, Photodermatologv 1: 174 –186. 5. Ehrsson, H., Eksborg, S., and Wallin, I., 1978, Metabolism of 8-methoxypsoralen in man: Identification and quantification of 8-hydroxypsoralen, Eur
J
Drug
Metab
Pharmacokinet 3: 125–128.
|
|